Navigation Links
$2.8 million grant boosts cystic fibrosis research at Queen's
Date:2/4/2011

Scientists at Queen's University Belfast have begun work into improving the lives of thousands of Cystic Fibrosis sufferers thanks to the award of a 1.74 million US-Ireland Research and Development Partnership grant.

The grant has been approved by the National Institutes of Health (NIH) in the USA with funding for the Queen's component provided by Health and Social Care Research and Development (HSC R&D Public Health Agency), Northern Ireland and the Medical Research Council. The grant is the largest ever to be awarded in the UK to study the microbiology of Cystic Fibrosis pulmonary infection.

The study is a collaborative US-Ireland international study with researchers in the Royal College of Surgeons Ireland, Dublin, the University of North Carolina at Chapel Hill, USA and the School of Pharmacy and the Centre for Infection and Immunity at Queen's University, Belfast.

Leading the study, Professor Stuart Elborn, Director of the Centre for Infection and Immunity in the School of Medicine, Dentistry and Biomedical Sciences at Queen's said; "The key goals of this study are to find out the role of anaerobes in causing damage to the lungs of people with Cystic Fibrosis. Anaerobes are bacteria that do not need oxygen to survive and we will determine whether their presence in the lung contributes to infection there.

We will also examine whether the bacteria are able to produce chemicals that can damage lung tissue and break down antibiotics given to treat lung infection. We will also look at how effective different antibiotics are in treating them."

He added; "The results of the study will be of important clinical relevance to people with Cystic Fibrosis because if we show that these anaerobes are contributing to infection and inflammation in the lungs of Cystic Fibrosis patients, in the future, patients could potentially be given more appropriate and effective antibiotics which should improve their clinical outcome and quality of life."

The research project has been funded for five years with an aim of recruiting a total of 450 Cystic Fibrosis patients across the three sites. The work will be performed in the 'US-Ireland Anaerobe Laboratory' in the Medical Biology Centre which has been recently refurbished - specifically to facilitate the delivery of this project.


'/>"/>

Contact: Claire O'Callaghan
c.ocallaghan@qub.ac.uk
44-289-097-5391
Queen's University Belfast
Source:Eurekalert

Related medicine news :

1. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
2. UofL Area Health Education Centers faculty, students make $6.8 million economic impact
3. Philanthropist invests $3.5 million in Buck Institutes Alzheimers drug development effort
4. 6 million euros for European Diabetes Research Network
5. 105 Million in U.S. Have Diabetes or Prediabetes, CDC Says
6. McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world
7. Khalifa Foundation grants MD Anderson $150 million for cancer research
8. LSTM leads new £6 million ($9.3 million) health systems knowledge consortium
9. NARSAD announces $12.6 million for new generation of brain and behavior research
10. Violence against mothers linked to 1.8 million female infant and child deaths in India
11. U.S. Spending Millions to See if Herbs Truly Work
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... PurhealthRX , a leading Health and Nutrition Company, is announcing the ... spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the amount ... into liquid products, while reducing costs to end users. , The team of researchers ...
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers were ... innovative way to use nonlinear optical imaging to confirm ... drugs. A ... show how researchers from BioPharmX and the Wellman Center ... a suite of imaging techniques in what is called ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
Breaking Medicine Technology: